Societe Generale’s Globus Medical GMED Stock Holding History

Societe Generale’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$488K	Buy	+20,460	New	+$491K	﹤0.01%	1715

Other funds holding GMED

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

AAM

Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Societe Generale's GMED Position: Q2 2016 in Review

Societe Generale opened a new position in Globus Medical (GMED) in Q2 2016: 20,460 shares worth $488K. The stake represents ﹤0.01% of the portfolio and ranks #1715 among its holdings.

209 funds tracked by Wall St. Rank hold GMED as of Q2 2016.

Societe Generale held 20,460 shares of Globus Medical worth $488K as of Q2 2016.
Globus Medical was a new Societe Generale position in Q2 2016.
Globus Medical made up ﹤0.01% of Societe Generale's portfolio in Q2 2016, its #1715 holding.
209 funds tracked by Wall St. Rank held Globus Medical as of Q2 2016.

Based on Societe Generale's 13F filing for Q2 2016, filed 2 Aug 2016.